# Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer

> **NCT01403324** · NA · TERMINATED · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 4 (actual)

## Conditions studied

- Thyroid Cancer
- Metastases

## Interventions

- **DRUG:** TSH stimulation

## Key facts

- **NCT ID:** NCT01403324
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-09
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Recruitment difficulties
- **Last updated:** 2016-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01403324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01403324, "Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01403324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*